{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:45:30Z","timestamp":1775785530367,"version":"3.50.1"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Numerous congenital or secondary diseases, including, heart disease, respiratory disease, sepsis and many others, can lead to neonatal death. B-type natriuretic peptide (BNP) is a peptide hormone secreted by ventricular cells following an increase in ventricular wall tension. BNP functions to promote vasodilation, diuresis, and sodium release to regulate blood pressure. BNP is a sensitive index reflecting ventricular function, which may aid the diagnosis and monitoring of various neonatal diseases. In neonates, there is currently no consensus on a reference BNP level, as the plasma BNP concentration of healthy newborns varies with age, peaks in the first week after birth, and then gradually decreased to a stable level. In disease states, the correlation between the plasma BNP concentration and the results of echocardiography is good, which is of great significance in the screening, monitoring, and prognosis evaluation of neonatal cardiovascular diseases, including congenital heart disease, patent ductus arteriosus, etcetera. It also facilitates the judgment of the efficacy of treatment and perioperative management. Moreover, the monitoring of plasma BNP concentration provides guidance for the diagnosis, evaluation, and treatment selection of certain neonatal respiratory diseases and neonatal sepsis. This review summarizes the normal BNP values and discusses the application value of BNP in relation to physiological and pathological aspects in neonates.<\/jats:p>","DOI":"10.3389\/fped.2021.767173","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T13:35:45Z","timestamp":1638884145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Application of B-Type Natriuretic Peptide in Neonatal Diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"Haotai","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinzheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","article-title":"Cardiac natriuretic peptides","volume":"17","author":"Goetze","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI7362","article-title":"Mechanical strain activates BNP gene transcription through a p38\/NF-kappaB-dependent mechanism","volume":"104","author":"Liang","year":"1999","journal-title":"J Clin Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s001090050179","article-title":"Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, angiotensin II","volume":"75","author":"Ruskoaho","year":"1997","journal-title":"J Mol Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.cardfail.2005.04.009","article-title":"Clinical value of NT-ProBNP and BNP in pediatric cardiology","volume":"11","author":"Nir","year":"2005","journal-title":"J Card Fail."},{"key":"B6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fped.2019.00271","article-title":"Cardiovascular biomarkers in amniotic fluid, umbilical arterial blood, umbilical venous blood, and maternal blood at delivery, and their reference values for full-term, singleton, cesarean deliveries","volume":"7","author":"Blohm","year":"2019","journal-title":"Front Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/pr.2012.88","article-title":"Use of cardiac biomarkers in neonatology","volume":"72","author":"Vijlbrief","year":"2012","journal-title":"Pediatr Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/heart.89.8.875","article-title":"Normal values of B type natriuretic peptide in infants, children, and adolescents","volume":"89","author":"Koch","year":"2003","journal-title":"Heart."},{"key":"B9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.18926\/AMO\/32809","article-title":"Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease","volume":"57","author":"Kunii","year":"2003","journal-title":"Acta Med Okayama."},{"key":"B10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cca.2005.11.005","article-title":"Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals","volume":"366","author":"Soldin","year":"2006","journal-title":"Clin Chim Acta."},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.earlhumdev.2008.05.008","article-title":"Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Italian newborns","volume":"85","author":"Mannarino","year":"2009","journal-title":"Early Hum Dev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2459\/JCM.0b013e32832c15fb","article-title":"Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases","volume":"10","author":"Cantinotti","year":"2009","journal-title":"J Cardiovasc Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1373\/clinchem.2009.126847","article-title":"Reference values for plasma B-type natriuretic peptide in the first days of life","volume":"55","author":"Cantinotti","year":"2009","journal-title":"Clin Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.earlhumdev.2010.04.003","article-title":"BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants","volume":"86","author":"Mannarino","year":"2010","journal-title":"Early Hum Dev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cellimm.2012.10.006","article-title":"Variation of B-type natriuretic peptide concentrations and intrauterine growth restriction: mother, fetus and newborn","volume":"26","author":"Garofoli","year":"2012","journal-title":"J Biol Regul Homeost Agents."},{"key":"B16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1017\/S1047951114002133","article-title":"BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?","volume":"25","author":"Cantinotti","year":"2015","journal-title":"Cardiol Young."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e022562","DOI":"10.1136\/bmjopen-2018-022562","article-title":"B-type natriuretic peptide reference interval of newborns from healthy and pre-eclamptic women: a prospective, multicentre, cross-sectional study","volume":"8","author":"Rodriguez","year":"2018","journal-title":"BMJ Open."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1097\/PCC.0000000000000966","article-title":"The utility of brain natriuretic peptide in pediatric cardiology: a review","volume":"17","author":"Neves","year":"2016","journal-title":"Pediatr Crit Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1111\/apa.13480","article-title":"B-type natriuretic peptide levels normalise in preterm infants without a patent ductus arteriosus by the fifth postnatal day","volume":"105","author":"Tauber","year":"2016","journal-title":"Acta Paediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.3390\/jcm9113602","article-title":"Uncomplicated monochorionic twins: two normal hearts sharing one placenta","volume":"9","author":"Torres","year":"2020","journal-title":"J Clin Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41390-018-0075-z","article-title":"Application of neonatologist performed echocardiography in the assessment and management of neonatal heart failure unrelated to congenital heart disease","volume":"84","author":"Levy","year":"2018","journal-title":"Pediatr Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jacc.2005.11.030","article-title":"B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure","volume":"47","author":"Iwanaga","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10741-014-9422-2","article-title":"The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update","volume":"19","author":"Cantinotti","year":"2014","journal-title":"Heart Fail Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0036-1583543","article-title":"B-Type cardiac natriuretic peptides in the neonatal and pediatric intensive care units","volume":"5","author":"Cantinotti","year":"2016","journal-title":"J Pediatr Intensive Care."},{"key":"B26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00246-003-0461-z","article-title":"B-type natriuretic peptide levels in congenital heart disease","volume":"25","author":"Cowley","year":"2004","journal-title":"Pediatr Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1475-097X.2005.00622.x","article-title":"Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload","volume":"25","author":"Holmgren","year":"2005","journal-title":"Clin Physiol Funct Imaging."},{"key":"B28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/eurheartj\/ehi773","article-title":"B-type natriuretic peptide in paediatric patients with congenital heart disease","volume":"27","author":"Koch","year":"2006","journal-title":"Eur Heart J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(10)61339-6","article-title":"Ventricular septal defect","volume":"377","author":"Penny","year":"2011","journal-title":"Lancet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1442-200X.2003.01716.x","article-title":"Clinical implication of plasma natriuretic peptides in children with ventricular septal defect","volume":"45","author":"Suda","year":"2003","journal-title":"Pediatr Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/1354750X.2011.649494","article-title":"B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study","volume":"17","author":"Jan","year":"2012","journal-title":"Biomarkers."},{"key":"B32","first-page":"192","article-title":"Correlation of plasma B-type natriuretic peptide with shunt volume in children with congenital heart disease involving left-to-right shunt","volume":"54","author":"Kavga","year":"2013","journal-title":"Hellenic J Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijcard.2009.07.029","article-title":"Diagnostic role of plasma BNP levels in neonates with signs of congenital heart disease","volume":"147","author":"Davlouros","year":"2011","journal-title":"Int J Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10741-019-09904-z","article-title":"Heart failure with reduced and preserved ejection fraction in adult congenital heart disease","volume":"25","author":"Vaikunth","year":"2020","journal-title":"Heart Fail Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/PEC.0b013e3182624a12","article-title":"B-type natriuretic peptide in the recognition of critical congenital heart disease in the newborn infant","volume":"28","author":"Das","year":"2012","journal-title":"Pediatr Emerg Care."},{"key":"B36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/chd.12744","article-title":"Circulating biomarkers of left ventricular hypertrophy in pediatric coarctation of the aorta","volume":"14","author":"Frank","year":"2019","journal-title":"Congenit Heart Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mpo.1155","article-title":"Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer","volume":"37","author":"Hayakawa","year":"2001","journal-title":"Med Pediatr Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.amjcard.2008.03.068","article-title":"Comparison of usefulness of tissue Doppler imaging versus brain natriuretic peptide for differentiation of constrictive pericardial disease from restrictive cardiomyopathy","volume":"102","author":"Sengupta","year":"2008","journal-title":"Am J Cardiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.17305\/bjbms.2016.670","article-title":"The association between brain natriuretic peptide and tissue Doppler parameters in children with hypertrophic cardiomyopathy","volume":"16","author":"\u00d6ner","year":"2016","journal-title":"Bosn J Basic Med Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1055\/s-0029-1231075","article-title":"Cardiogenic shock in a neonate with enterovirus myocarditis","volume":"221","author":"Meyer","year":"2009","journal-title":"Klinische Padiatrie."},{"key":"B41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0300-1652.218413","article-title":"Comparison between brain natriuretic peptide and calcitonin gene-related peptide in children with dilated cardiomyopathy and controls","volume":"58","author":"Noori","year":"2017","journal-title":"Niger Med J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1177\/0300060519831187","article-title":"Use of high-sensitivity cardiac troponin I levels for early diagnosis of myocardial injury after neonatal asphyxia","volume":"47","author":"Jiang","year":"2019","journal-title":"J Int Med Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3109\/14767058.2011.644365","article-title":"The assessment of time-dependent myocardial changes in infants with perinatal hypoxia","volume":"25","author":"Cetin","year":"2012","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000339117","article-title":"Cardiac biomarkers as indicators of hemodynamic adaptation during postasphyxial hypothermia treatment","volume":"102","author":"Vijlbrief","year":"2012","journal-title":"Neonatology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cjca.2016.08.004","article-title":"Preoperative optimization of the heart failure patient undergoing cardiac surgery","volume":"33","author":"Pichette","year":"2017","journal-title":"Can J Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1747-0803.2010.00396.x","article-title":"B-type natriuretic peptide: perioperative patterns in congenital heart disease","volume":"5","author":"Niedner","year":"2010","journal-title":"Congenital Heart Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/PCC.0b013e31828a89b9","article-title":"Response of cardiac endocrine function to surgery stress is age dependent in neonates and children with congenital heart defects: consequences in diagnostic and prognostic accuracy of brain natriuretic peptide measurement","volume":"14","author":"Cantinotti","year":"2013","journal-title":"Pediatr Crit Care Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00246-014-1046-8","article-title":"Preoperative factors as a predictor for early postoperative outcomes after repair of congenital transposition of the great arteries","volume":"36","author":"Kim","year":"2015","journal-title":"Pediatr Cardiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1053\/j.jvca.2016.09.008","article-title":"Perioperative brain natriuretic peptide in pediatric cardiac surgery patients: its association with postoperative outcomes","volume":"31","author":"Kanazawa","year":"2017","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"B50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.aprim.2012.12.013","article-title":"Predictive value of B-type natriuretic peptide level on the postoperative course of infants with congenital heart disease","volume":"15","author":"Nahum","year":"2013","journal-title":"Isr Med Assoc J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00246-014-0872-z","article-title":"Factors associated with serum B-type natriuretic peptide in infants with single ventricles","volume":"35","author":"Butts","year":"2014","journal-title":"Pediatr Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0140-6736(17)31002-4","article-title":"Neonatal sepsis","volume":"390","author":"Shane","year":"2017","journal-title":"Lancet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5935\/0103-507X.20190060","article-title":"The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock","volume":"31","author":"Pandompatam","year":"2019","journal-title":"Rev Bras Ter Intensiva."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e8954","DOI":"10.7759\/cureus.8954","article-title":"The role of brain natriuretic peptide as a prognostic marker for sepsis","volume":"12","author":"Bhandari","year":"2020","journal-title":"Cureus."},{"key":"B55","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpeds.2013.09.027","article-title":"Myocardial dysfunction in pediatric septic shock","volume":"164","author":"Raj","year":"2014","journal-title":"J Pediatr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0231","DOI":"10.1097\/CCE.0000000000000231","article-title":"Myocardial dysfunction is independently associated with mortality in pediatric septic shock","volume":"2","author":"Lautz","year":"2020","journal-title":"Crit Care Explor."},{"key":"B57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/0885066616685247","article-title":"Characterization of myocardial dysfunction in fluid- and catecholamine-refractory pediatric septic shock and its clinical significance","volume":"34","author":"Williams","year":"2019","journal-title":"J Intensive Care Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1542\/peds.2015-3730","article-title":"Patent ductus arteriosus in preterm infants","author":"Benitz","year":"2016","journal-title":"Pediatrics."},{"key":"B59","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamapediatrics.2015.0987","article-title":"Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates","volume":"169","author":"Jain","year":"2015","journal-title":"JAMA Pediatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.jp.7211383","article-title":"Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates","volume":"25","author":"Sanjeev","year":"2005","journal-title":"J Perinatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1542\/peds.2004-1837","article-title":"Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants","volume":"115","author":"Choi","year":"2005","journal-title":"Pediatrics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpeds.2005.03.040","article-title":"The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates","volume":"147","author":"Flynn","year":"2005","journal-title":"J Pediatr."},{"key":"B63","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1203\/PDR.0b013e3181799594","article-title":"B-type natriuretic peptide to predict ductus intervention in infants <28 weeks","volume":"64","author":"Czernik","year":"2008","journal-title":"Pediatr Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/PAI.0b013e3181f1ef0b","article-title":"Point-of-care testing for B-type natriuretic peptide in premature neonates with patent ductus arteriosus","volume":"41","author":"Kalra","year":"2011","journal-title":"Ann Clin Lab Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4070\/kcj.2012.42.3.192","article-title":"B-type natriuretic peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants","volume":"42","author":"Kim","year":"2012","journal-title":"Korean Circ J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000343034","article-title":"Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants?","volume":"103","author":"Lee","year":"2013","journal-title":"Neonatology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1111\/apa.12273","article-title":"B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants","volume":"102","author":"Mine","year":"2013","journal-title":"Acta Paediatr."},{"key":"B68","first-page":"1072","article-title":"Value of B-type natriuretic peptide in diagnosis and treatment of haemodynamically significant patent ductus arteriosus in early preterm infants","volume":"31","author":"Gao","year":"2016","journal-title":"Chinese J Appl Clin Pediatrics."},{"key":"B69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.14734\/PN.2018.29.2.78","article-title":"Effectiveness of B-type natriuretic peptide in caring for preterm infants","volume":"29","author":"Lee","year":"2018","journal-title":"Perinatology."},{"key":"B70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.24875\/ACME.M21000172","article-title":"B-type brain natriuretic peptide as marker of hemodynamicoverload of the patent ductus arteriosus in the preterm infant","volume":"91","author":"Parra-Bravo","year":"2021","journal-title":"Arch Cardiol Mex"},{"key":"B71","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3345\/kjp.2016.59.4.183","article-title":"Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus","volume":"59","author":"Jeong","year":"2016","journal-title":"Korean J Pediatr."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1542\/peds.2014-1995","article-title":"Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review","volume":"135","author":"Kulkarni","year":"2015","journal-title":"Pediatrics."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1111\/apa.12892","article-title":"B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants","volume":"104","author":"K\u00f6nig","year":"2015","journal-title":"Acta Paediatr."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7363\/050210","article-title":"Pre-symptomatic prediction of morbitidies in preterm infants with patent ductus arteriosus by targeted neonatal echocardiography and brain-type natriuretic peptide","author":"Elsayed","year":"2016","journal-title":"J Pediatric Neonatal Individual Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41390-018-0182-x","article-title":"Exploration of potential biochemical markers for persistence of patent ductus arteriosus in preterm infants at 22-27 weeks' gestation","volume":"86","author":"Olsson","year":"2019","journal-title":"Pediatr Res."},{"key":"B76","first-page":"333","article-title":"Serial serum brain-type natriuretic peptide (BNP) identifies compromised blood flow in infants with hemodynamically significant patent ductus arteriosus","volume":"6","author":"Elsayed","year":"2017","journal-title":"J Pediatric Neonatal Individual Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","article-title":"Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"319","author":"Mitra","year":"2018","journal-title":"JAMA."},{"key":"B78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2009.12.045","article-title":"B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus","volume":"157","author":"Hsu","year":"2010","journal-title":"J Pediatr."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/s41598-020-61291-w","article-title":"Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus","volume":"10","author":"Oh","year":"2020","journal-title":"Sci Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3345\/kjp.2017.60.6.175","article-title":"Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants","volume":"60","author":"Shin","year":"2017","journal-title":"Korean J Pediatr."},{"key":"B81","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5863\/1551-6776-25.6.507","article-title":"Late acetaminophen therapy for patent ductus arteriosus in the preterm neonate","volume":"25","author":"King","year":"2020","journal-title":"J Pediatr Pharmacol Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2352-4642(19)30402-X","article-title":"Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"4","author":"GBD","year":"2020","journal-title":"Lancet Child Adolesc Health."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/heartjnl-2012-302543","article-title":"Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study","volume":"98","author":"Khoshnood","year":"2012","journal-title":"Heart."},{"key":"B84","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/CIRCRESAHA.116.308996","article-title":"Heart failure in pediatric patients with congenital heart disease","volume":"120","author":"Hinton","year":"2017","journal-title":"Circ Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12519-015-0039-x","article-title":"Cardiac biomarkers in children with congenital heart disease","volume":"11","author":"Sugimoto","year":"2015","journal-title":"World J Pediatr."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1161\/01.CIR.0000129305.25115.80","article-title":"Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion","volume":"109","author":"Hopkins","year":"2004","journal-title":"Circulation."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e1484","DOI":"10.1542\/peds.2007-1856","article-title":"B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children","volume":"121","author":"Maher","year":"2008","journal-title":"Pediatrics."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jacc.2009.06.020","article-title":"Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study","volume":"54","author":"Law","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1515\/CCLM.2010.251","article-title":"Diagnostic accuracy of B-type natriuretic hormone for congenital heart disease in the first month of life","volume":"48","author":"Cantinotti","year":"2010","journal-title":"Clin Chem Lab Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.cca.2011.08.030","article-title":"Clinical relevance of time course of BNP levels in neonates with congenital heart diseases","volume":"412","author":"Cantinotti","year":"2011","journal-title":"Clin Chim Acta."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1080\/14767058.2019.1633300","article-title":"Maternal and cord blood homocysteine, vitamin B12, folate, and B-type natriuretic peptide levels at term for predicting congenital heart disease of the neonate: a case-control study","volume":"33","author":"Sahin-Uysal","year":"2020","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ajem.2019.06.045","article-title":"Cardiomegaly on chest radiographs as a predictor of heart disease in the pediatric population","volume":"38","author":"Dasgupta","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1080\/14767058.2018.1536740","article-title":"An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome","volume":"33","author":"Nakwan","year":"2020","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1080\/14767058.2018.1543392","article-title":"Correlation between changes in brain natriuretic peptide and echocardiographic features in persistent pulmonary hypertension of newborn","volume":"33","author":"Fu","year":"2020","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1542\/peds.2004-0525","article-title":"Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"114","author":"Reynolds","year":"2004","journal-title":"Pediatrics."},{"key":"B98","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/ajop.Ajop_3_17","article-title":"Role of brain-type natriuretic peptide in rapid diagnosis and prognosis of persistent pulmonary hypertension of the newborn","volume":"30","author":"Latif","year":"2017","journal-title":"Alex J Pediatr"},{"key":"B99","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000499082","article-title":"Accuracy of brain natriuretic peptide for diagnosing pulmonary hypertension in severe bronchopulmonary dysplasia","volume":"116","author":"Avitabile","year":"2019","journal-title":"Neonatology."},{"key":"B100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/RRN.S42236","article-title":"B-type natriuretic peptide is a biomarker for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia","volume":"3","author":"Kandasamy","year":"2013","journal-title":"Res Rep Neonatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00246-019-02100-8","article-title":"Screening echocardiography and brain natriuretic peptide levels predict late pulmonary hypertension in infants with bronchopulmonary dysplasia","volume":"40","author":"Behere","year":"2019","journal-title":"Pediatr Cardiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jpeds.2011.06.038","article-title":"B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertension","volume":"160","author":"Vijlbrief","year":"2012","journal-title":"J Pediatr."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1900788","DOI":"10.1183\/13993003.00788-2019","article-title":"European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia","volume":"55","author":"Duijts","year":"2020","journal-title":"Eur Respir J."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/ppul.22942","article-title":"B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?","volume":"49","author":"Kalra","year":"2014","journal-title":"Pediatr Pulmonol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annepidem.2020.11.007","article-title":"Prevalence and mortality in children with congenital diaphragmatic hernia: a multi-country study","volume":"56","author":"Politis","year":"2020","journal-title":"Ann Epidemiol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpedsurg.2014.11.009","article-title":"Brain-type natriuretic peptide levels correlate with pulmonary hypertension and requirement for extracorporeal membrane oxygenation in congenital diaphragmatic hernia","volume":"50","author":"Partridge","year":"2015","journal-title":"J Pediatr Surg."},{"key":"B107","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/pr.2014.136","article-title":"B-type natriuretic peptide: prognostic marker in congenital diaphragmatic hernia","volume":"76","author":"Steurer","year":"2014","journal-title":"Pediatr Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jpeds.2020.09.064","article-title":"Longitudinal B-Type Natriuretic peptide levels predict outcome in infants with congenital diaphragmatic hernia","volume":"229","author":"Guslits","year":"2020","journal-title":"J Pediatr"},{"key":"B109","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000499361","article-title":"European consensus guidelines on the management of respiratory distress syndrome - 2019 update","volume":"115","author":"Sweet","year":"2019","journal-title":"Neonatology."},{"key":"B111","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00246-003-0578-0","article-title":"Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress","volume":"25","author":"Koulouri","year":"2004","journal-title":"Pediatr Cardiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/ppul.21111","article-title":"Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injury","volume":"44","author":"Reel","year":"2009","journal-title":"Pediatr Pulmonol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.767173\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T13:35:53Z","timestamp":1638884153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.767173\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":112,"alternative-id":["10.3389\/fped.2021.767173"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.767173","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"article-number":"767173"}}